Regional Monitoring EECA
by ECUO PLWH
Showing 1-20 of 20 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml81.46855407.341407.342015Not specifiedNot specifiedNot specified
2Republic of LithuaniaInsurance FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml391.5211391.521391.522016YesYesNot specified
3Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.8375530975231752015Not specifiedNot specifiedNot specified
4Republic of MoldovaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml13.85510113.855107063.5Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
5Republic of MoldovaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.4321125512.162252736IDA FoundationNot specifiedNot specifiedNot specified
6Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml74.576-5372.88--2015Not specifiedYesNot specified
7UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml0.236100717051.18201434237692.122015Not specifiedNot specifiedNot specified
8Russian FederationGovernmentAesica Queenborough LimitedKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml21.451050121.45105022522.52016YesYesYes
9GeorgiaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16255560.8513100.8partnership for supply. chain management (PFSCM)2015NoYesNot specified
10Republic of TajikistanGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--2015Not specifiedNot specifiedNot specified
11GeorgiaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.1640560.88486.4partnership for supply. chain management (PFSCM)2016YesYesNot specified
12Republic of UzbekistanGlobal FundAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--2015Not specifiedNot specifiedNot specified
13Republic of BelarusGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml60.8105160.81056384UNDP/UNICEF2016YesYesNot specified
14UkraineGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml64.773357164.773357217432.892016YesYesNot specified
15Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.7982505308.995015449.52015Not specifiedNot specifiedNot specified
16Republiс of AzerbaijanGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml42.09821005210.4942088405.82015YesYesNot specified
17Republic of UzbekistanGlobal FundAesica Queenborough LimitedKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.165560.8160.82016NoYesYes
18Republic of KazakhstanGovernmentAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.37211175511.86223526507.12015Not specifiedNot specifiedNot specified
19Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml88.762-5443.81--2015Not specifiedNot specifiedNot specified
20Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml92.2281555461.143114295.34National Health Service (NHC)2016Not specifiedNot specifiedNot specified